Newborn Screening for Congenital Adrenal Hyperplasia inthe Netherlands
- 1 December 2001
- journal article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 108 (6) , 1320-1324
- https://doi.org/10.1542/peds.108.6.1320
Abstract
Objective. To evaluate whether congenital adrenal hyperplasia (CAH) patients can be detected by newborn screening before the occurrence of life-threatening salt wasting and whether the prevalence, specificity, and sensitivity are adequate enough for a routine screening procedure.Keywords
This publication has 10 references indexed in Scilit:
- Effect of Newborn Screening for Congenital Adrenal HyperplasiaArchives of Pediatrics & Adolescent Medicine, 1999
- Neonatal Screening for 21-Hydroxylase Deficient Congenital Adrenal Hyperplasia--The Role of CYP21 AnalysisJournal of Clinical Endocrinology & Metabolism, 1999
- Neonatal screening of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Lille experience 1980–1996Archives de Pédiatrie, 1999
- Benefits of Neonatal Screening for Congenital Adrenal Hyperplasia (21-Hydroxylase Deficiency) in SwedenPediatrics, 1998
- The British Paediatric Surveillance Unit — a pioneering method for investigating the less common disorders of childhood. Report of a seminar held in June 1995Child: Care, Health and Development, 1998
- Current status of neonatal screening for congenital adrenal hyperplasiaCurrent Opinion in Pediatrics, 1997
- Improving the efficacy of newborn screening for congenital adrenal hyperplasia by adjusting the cut-off level of 17α-hydroxyprogesterone to gestational ageScreening, 1994
- Presentation, acute illness, and learning difficulties in salt wasting 21-hydroxylase deficiency.Archives of Disease in Childhood, 1994
- Screening of half a million Swedish newborn infants for congenital adrenal hyperplasiaScreening, 1992
- Learning Disabilities in Children With Congenital Adrenal HyperplasiaJournal of Child Neurology, 1991